Last reviewed · How we verify
NCT06611566: VRalgia
VR-guided Exercise and Mindfulness Program for People with Chronic Pain
NA trial testing VR-guided aerobic exercise in Chronic Pain in 27 participants. Completed in 1 March 2023.
1 March 2023
Quick facts
| Lead sponsor | Inland Norway University of Applied Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 27 |
| Start date | 1 August 2022 |
| Primary completion | 1 March 2023 |
| Estimated completion | 1 March 2023 |
| Sites | 2 locations across Norway |
Drugs / interventions tested
- VR-guided aerobic exercise
- VR-guided mindfulness exercise
- TV-guided aerobic exercises
- TV-guided mindfulness exercises
Conditions studied
- Chronic Pain — all drugs for Chronic Pain →
- Rehabilitation — all drugs for Rehabilitation →
Sponsor
Inland Norway University of Applied Sciences
Who can join
18 and older, any sex, with Chronic Pain or Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study we assessed the feasibility of a VR-guided intervention seeking to improve physical fitness in individuals with chronic pain. In a randomised controlled trial with a cross-over design and participants in rehabilitation for chronic pain were asked to perform, in a counter-balanced order, five minutes of aerobic exercise following identical instructions given through either a VR headset or TV screen. The procedures were then repeated with mindfulness exercises. Heart rate (HR) was monitored throughout all four sessions and participants self-reported perceived exercise intensity, benefit, relaxation, and reward. Paired Student's t-test, Wilcoxon signed rank test and McNemar's test were performed to compare the outcome variables across sessions for individuals, as appropriate.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
VR-guided exercise and mindfulness program for people with chronic pain: a randomised controlled cross-over pilot trial.
Provan SA, Calogiuri G, Røset L, Mariussen M, et al · · 2025 · PMID 40119474 · DOI 10.1186/s13102-025-01102-9
Verify or expand the search:
- PubMed search for NCT06611566
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Pain
Currently open trials in the same condition.
- NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
- NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
- NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
- NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
- NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
Other Inland Norway University of Applied Sciences trials
Trials by the same sponsor.
- NCT07159815 — REACT - Resistance Exercise After Cancer Treatment · NA · recruiting
- NCT04637178 — Predicting the Efficacy of Resistance Exercise Training for Improving Endurance Performance · NA · completed
- NCT04611646 — Effects of Heat-suit Training on Biological and Performance Characteristics in Elite Cyclists · NA · completed
- NCT04545190 — RibOSE - Glucose and Resistance Exercise Training · NA · completed
- NCT04196725 — Effect of Lifestyle Intervention vs Physical Therapy Treatment in Patients With Secondary Lymphedema After Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06611566 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inland Norway University of Applied Sciences
- Last refreshed: 25 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611566.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing